Detalles de la búsqueda
1.
Ponatinib delays the growth of solid tumours by remodelling immunosuppressive tumour microenvironment through the inhibition of induced PD-L1 expression.
Br J Cancer
; 129(6): 1007-1021, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37400678
2.
Repurposing Ponatinib as a PD-L1 Inhibitor Revealed by Drug Repurposing Screening and Validation by In Vitro and In Vivo Experiments.
ACS Pharmacol Transl Sci
; 6(2): 281-289, 2023 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36798474
3.
Multifaceted Nano-DEV-IL for Sustained Release of IL-12 to Avert the Immunosuppressive Tumor Microenvironment and IL-12-Associated Toxicities.
ACS Appl Mater Interfaces
; 15(16): 20012-20026, 2023 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068138
4.
Tumor Antigen-Primed Dendritic Cell-Derived Exosome Synergizes with Colony Stimulating Factor-1 Receptor Inhibitor by Modulating the Tumor Microenvironment and Systemic Immunity.
ACS Biomater Sci Eng
; 9(11): 6409-6424, 2023 11 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37870457
5.
SARS-CoV-2 Spike Protein-Activated Dendritic Cell-Derived Extracellular Vesicles Induce Antiviral Immunity in Mice.
ACS Biomater Sci Eng
; 8(12): 5338-5348, 2022 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36445062
Resultados
1 -
5
de 5
1
Próxima >
>>